Skin Disorders News

Gaining weight can raise the risk for atopic dermatitis and possibly other immune-mediated skin diseases in children, whereas losing weight can reduce this risk, according to a study.

SAN ANTONIO — Patients with urticaria who do not respond to omalizumab have other options for treatment, David A. Khan, MD, said during the 16th Annual Allergy, Asthma & Immunology CME Conference.

SAN ANTONIO — Different patterns of allergic contact dermatitis on the head and face may provide clues about what caused these outbreaks, Heather O’Connell, PA-C, said at the 16th Annual Allergy, Asthma & Immunology CME Conference.

Tralokinumab improved epidermal pathology, reduced inflammation and changed significant skin biomarkers in patients with atopic dermatitis, according to a study published in The European Journal of Allergy and Clinical Immunology.

Dupilumab showed continuous efficacy and safety in the long-term treatment of atopic dermatitis, according to a study.

Delgocitinib cream has shown efficacy in the treatment of hand eczema in two phase 3 trials.

Cendakimab was effective and generally safe in the treatment of moderate to severe atopic dermatitis in adults, according to a press release.

Omalizumab is effective and safe for the treatment of chronic urticaria, demonstrating high discontinuation due to well-controlled disease, according to a study.

Patients with cold urticaria and symptomatic dermographism experienced clinically meaningful and statistically significant complete responses with barzolvolimab, according to a webinar by Celldex Therapeutics.

A new imaging device effectively monitored skin texture changes in patients with skin of color with atopic dermatitis and xerosis following a prebiotic skincare regimen, according to a study.